Mia's Feed
Medical News & Research

Huntsman Cancer Institute Expands Proton Therapy Capacity to Enhance Cancer Care in the Mountain West

Huntsman Cancer Institute Expands Proton Therapy Capacity to Enhance Cancer Care in the Mountain West

Share this article

Huntsman Cancer Institute is expanding its Proton Therapy Center, doubling treatment capacity to improve access to precision cancer care across the Mountain West region including Utah, Idaho, Montana, Nevada, and Wyoming.

3 min read

Huntsman Cancer Institute at the University of Utah has announced a significant expansion of its renowned Proton Therapy Center, which will double its treatment capacity and broaden access to this advanced cancer treatment technology across the Mountain West region, including Utah, Idaho, Montana, Nevada, and Wyoming.

The expansion involves constructing a new approximately 9,000-square-foot, three-story vault adjacent to the existing proton therapy unit. This facility will house state-of-the-art treatment equipment, allowing the institute to serve more patients and treat a wider range of cancer types. The current proton therapy facility, opened in 2021, is the only one of its kind in the Mountain West, and this expansion aims to address growing demand.

Historically, the facility has provided specialized radiation treatments to both pediatric and adult patients, focusing on cancers such as brain and spinal cord tumors. Due to its success, the current capacity has been limited, leading to highly selective patient treatment. Dr. Matthew Poppe, clinical director of the Proton Therapy Center, emphasized that the new vault will enable the institute to treat more patients and improve regional access to this precise form of radiation therapy.

Proton therapy offers a precise targeting of cancerous tissues, utilizing high-energy beams that stop at the tumor, minimizing damage to surrounding healthy tissue. This precision makes it especially advantageous for treating pediatric patients and sensitive regions like the brain and spinal cord. The second treatment vault will also allow the institute to expand treatment options to additional cancer types, including head and neck cancers and breast cancer.

Adding a second proton therapy vault is a transformative step for Huntsman Cancer Institute, as it will help alleviate the travel burden on patients who otherwise need to travel hundreds of miles to centers in Phoenix, Seattle, or San Diego. The new vault will enable closer-to-home treatment for patients from the Mountain West, ensuring comprehensive and coordinated care.

Dr. Amit Maity, chair of the Department of Radiation Oncology, noted that the expansion will foster more partnerships with other hospitals and clinics, helping to bring advanced cancer treatments nearer to patients. Mary Beckerle, CEO of Huntsman Cancer Institute, highlighted that this project reflects a strong commitment to innovation and compassionate care, positioning the institute as a regional leader in cutting-edge cancer therapy.

This development marks a major milestone in enhancing cancer treatment infrastructure in the region, ensuring more patients can benefit from precise, effective proton therapy without excessive travel or delays.

source: https://medicalxpress.com/news/2025-08-proton-therapy-center-expansion-significantly.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Innovative Breast Cancer Treatment Merges Light Therapy and Iron-Induced Cell Death

A novel dual-action breast cancer therapy combines light-activated drugs with iron-based cell destruction, offering a targeted and safer treatment option with fewer side effects.

Semaglutide Usage May Double the Risk of Developing Neovascular Macular Degeneration

Studies reveal that semaglutide, a popular diabetes medication, may double the risk of developing neovascular age-related macular degeneration in older adults, highlighting the need for eye health monitoring during long-term treatment.

Innovative Strategies for Assessing Rheumatic Reactions in Cancer Immunotherapy Patients

A multidisciplinary approach is transforming how healthcare professionals diagnose and manage rheumatic reactions in cancer immunotherapy, emphasizing integrated care and cutting-edge research in onco-rheumatology.

Increased Risk of Mortality Linked to Sleep Deprivation in Elderly Patients with Epilepsy

Sleep deprivation significantly increases the risk of death among older adults with epilepsy, highlighting the need for routine sleep assessments in this vulnerable group.